Announcements Trials
Browse Landscape

Phase

Phase 3 21Phase 2 13Phase NA 4Phase 1/2 4Phase 1 4Phase 4 2Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER 7INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Neoplasms 2Thyroid Diseases 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Surgical Procedures, Operative × Clear all
NCT00902083 2012-04-09

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Tumor-Agnostic

Neoplasms

NCT00902122 2012-04-09

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Head & Neck

Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡